Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
- First Posted Date
- 2012-01-27
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01520246
Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma
Completed
- Conditions
- First Posted Date
- 2012-01-27
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 100
- Registration Number
- NCT01520233
Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder
Completed
- Conditions
- First Posted Date
- 2012-01-18
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 60
- Registration Number
- NCT01511575
Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
Completed
- Conditions
- First Posted Date
- 2012-01-16
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 99
- Registration Number
- NCT01510600
Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial
Completed
- Conditions
- First Posted Date
- 2012-01-10
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 10
- Registration Number
- NCT01507441
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-01-04
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 292
- Registration Number
- NCT01503515
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
🇨🇦Hospital for Sick Children, Toronto, Ontario, Canada
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
- First Posted Date
- 2012-01-04
- Last Posted Date
- 2024-08-30
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 570
- Registration Number
- NCT01503632
- Locations
- 🇺🇸
Advocate Lutheran General Hospital, Park Ridge, Illinois, United States
🇺🇸UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
🇺🇸Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2012-01-02
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 71
- Registration Number
- NCT01503086
- Locations
- 🇺🇸
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸Alfred I duPont Hospital for Children, Wilmington, Delaware, United States
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
Completed
- Conditions
- First Posted Date
- 2011-12-28
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01500499
Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia
Completed
- Conditions
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 10
- Registration Number
- NCT01498302
© Copyright 2024. All Rights Reserved by MedPath